NL-OMON55308已完成不适用
Platelet analysis in patients with haematological diseases with increased risk of thrombosis and bleeding - PART
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 102
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Patients with hematological disease and drugs with increased bleeding or
- •thrombosis risk
- •For cases: with thrombosis or bleeding
- •For controls: without bleeding or thrombosis
排除标准
- •- <18 year. - >1 platelet inhibiting drug
研究者
相似试验
已完成
不适用
Platelet rEactivity in patieNts with DrUg eLUting stent and balancing risk of bleeding and ischeMic eventPatients with ACS or elective indications undergoing PCI with drug-eluting stent implantation.JPRN-UMIN000020332Toho University Ohashi Medical Center6,422
尚未招募
Unknown
Immature platelet fraction in patients infected with COVID-19CTRI/2023/12/060412Rashmi Jain Gupta
进行中（未招募）
不适用
Assessment of platelet function in patients with chronic autoimmune thrombocytopenic purpura (cAITP) treated with the thrombopoietin receptor (MPL) agonist EltrombopagEUCTR2008-006143-40-ATMedizinische Universität Wien, Universitätsklinik Innere Medizin I30
进行中（未招募）
1 期
Assessment of platelet-dependent thrombosis by an ex vivo arterial injury model: a placebo controlled trial of Clopidogrel as antiplatelet therapy in patients with type 2 diabetes mellitus and coronary artery disease. - Platelet-dependent thrombosis: a placebo-controlled trial of antiplatelet therapy (Clopidogrel)Type 2 Diabetes Mellitus and Coronary Artery DiseaseEUCTR2006-003745-16-GBewcastle upon Tyne Hospitals NHS Trust225
尚未招募
Unknown
Platelet parameters in COVID-19 infectioCTRI/2023/06/054501Rashmi Jain Gupta